Will Trump’s 200% Tariffs Hurt India’s Pharma Exports? Here’s What We Know
US President Donald Trump has announced that imported generic medicines will remain exempt from tariffs for the next two years but warned they could face duties of up to 100 per cent initially and 200 per cent later if manufacturers fail to shift production to the United States.
Read More